$1,191,348,081

Department of Veterans Affairs·Department of Veterans Affairs

to MCKESSON CORPORATION

veteransexpired

WORK BEGAN2026-04-01·LATEST ACTION2026-05-29·SOURCEUSASPENDING·SOURCE IDCONT_AWD_36C24026K1007_3600_36W79720D0001_3600

Award description

EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

VA pharmaceutical supply contract with McKesson for April 2026 drug distribution to veteran medical facilities.

Sub-sectors

va-pharmaceutical-supplyprime-vendor-contract

Why this matters

Prime vendor contracts ensure reliable, cost-effective medication access across the VA's nationwide hospital and clinic network serving 9+ million veterans.

Supply-chain signal

McKesson's role as PPV consolidates VA drug procurement through a single distributor, affecting upstream pharma manufacturers and downstream VA pharmacy operations.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-31. Cost: $0.002675.

Period of performance

Start

2026-04-01

End

2026-04-30

Status

expired41 days ago

Recipient

MCKESSON CORPORATION

UEI S1RUKWWRYFL6

View full profile →

Other awards from this recipient

See all →

2026-05-01EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH$1.2B

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_36C24026K1007_3600_36W79720D0001_3600.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.